Results from a Study with Immunocidin® Equine for Sarcoid Tumors Being Published in the Journal of Equine Veterinary Science
An Iowa State University study concluded that Immunocidin Equine was effective in 52.9% of the cases enrolled (that had a known outcome) after 2-5 injections. The treatment was deemed safe, with swelling the only side effect.
Positive Effect of Settle® on Postpartum Involution Published in the Journal of Equine Veterinary Science
Data from a study with Settle® has been published in the Journal of Equine Veterinary Science. The data show a positive effect of Settle on postpartum uterine involution in the mare, particularly with a two-dose regimen.
Researchers Present Settle® Data to International Veterinary Scientists in Germany
Data from a University of Kentucky study assessing the effect of Settle on histological involution, cell-mediated immunity of the uterus, and clinical endpoints associated with involution was presented in Germany today.
Immunocidin® with Chemotherapy Extends Survival Time in Study with Canine Lymphoma and Osteosarcoma Patients
Positive data from a retrospective study using Immunocidin® with chemotherapy in dogs with Lymphoma and Osteosarcoma were presented at the Veterinary Cancer Society Annual Conference by Dr. Jeannette Kelly, vet oncologist.
Amplimune® Administered in Calves Prior to Shipment Shows Economic Benefit
Data from a University of Minnesota research study presented by Dr. Luciano Caixeta at the AABP annual conference in St. Louis, MO last week shows an economic benefit to the use of Amplimune in calves prior to shipping.
Amplimune® Administered in Calves Prior to Shipment Demonstrates a Reduced Likelihood of Pneumonia Upon Arrival
Amplimune® given to calves prior to shipment has been shown to reduce the likelihood of pneumonia on arrival. Data from a 1,360-calf study was presented at the 2019 American Dairy Science Association Annual Meeting today.